In this regard, in our previous study, we also found a significant reduction of insulin resistance, together with increased circulating levels of adiponectin and decreased concentrations of IL-6 in mice with MetS supplemented with CSAT+®, without significant changes in adiposity [18]. The gene discussed is ADIPOQ; the disease is metabolic syndrome.